Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02667353Completed
Open-label trial in major depressive disorder (MDD), sponsored by UZ Leuven. Primary endpoints: Change in hippocampal volume at 6 months, Change in brain derived neurotrophic factor at 4 weeks and 1 more. Started Jun 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02667353.